Page 7 - Albert Bourla News Today

The Future of Everything Festival brings together global newsmakers to discuss trends and opportunities across business, technology, finance, government and culture.

Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for direct-to-consumer online platform.

On Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year over year, beating the consensus of $0.54. The company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an unfavorable impact of foreign exchange of $107 million, or 1%. The U.S. drugmaker reported sales of $14.9 billion, down 20%, beating the consensus of $14.2 billion. Excluding contributions from Comirnaty and Paxlovid, revenues totaled $12.5 billion, an increase of

14:19 ET -- Pfizer is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The New York-based biopharmaceutical firm said...

Pfizer had a surprise beat in its COVID portfolio despite dim forecasts, but the company is still not feeling the love in its stock.

Shares of the New York-based drugmaker, which have lost 11% of their value this year, rose 4% to $26.64

A double beat on earnings, plus raised bottom-line guidance, made the company a hot item on Hump Day.

PFE earnings call for the period ending March 31, 2024.

A double beat on earnings, plus raised bottom-line guidance, made the company a hot item on Hump Day.

Pfizer CEO Albert Bourla predicts normal life will return within a year and adds we may need annual Covid shots : Rashtra News Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April